Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX) is a Medical Devices company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $5.4M; returns 1 day +3.0%, 1 week -3.3%, 1 year -98.0%.

VolitionRx Ltd (VNRX) is a multi-national epigenetics biotechnology company developing non-invasive blood-based diagnostic tests leveraging its proprietary Nu.Q platform, which detects nucleosome biomarkers for early disease identification.

Groups VNRX belongs to

• Biotechnology
• Recent Reverse Splits
• Epigenetics
• Health Diagnostics and Imaging
• Life Sciences
• Early Cancer Detection
• Oncology
• Healthcare
• Clinical Stage Biotech
• Healthcare Innovation
• Precision Medicine

VNRX financial model: income statement, cash flow and balance sheet